Table 3. Incidence of laboratory data abnormality.
|
Age group (y.o.) |
|||||||
|---|---|---|---|---|---|---|---|
|
65–74
y.o. |
75–84
y.o. |
65–74 vs. 75–84y.o. | |||||
| Olmesartan plus CCB (n=1459) | Olmesartan plus diuretic (n=1459) | P-value | Olmesartan plus CCB (n=1109) | Olmesartan plus diuretic (n=1114) | P-value | P-value | |
| Hyperuricemia | 32 (2.2) | 85 (5.8) | <0.001 | 29 (2.6) | 68 (6.1) | <0.001 | 0.53 |
| Increased creatinine | 3 (0.2) | 8 (0.6) | 0.23 | 7 (0.6) | 1 (0.1) | 0.038 | 1.0 |
| Anemia | 5 (0.3) | 4 (0.3) | 1.0 | 3 (0.3) | 5 (0.5) | 0.73 | 0.81 |
| Hyperkalemia | 7 (0.5) | 4 (0.3) | 0.55 | 11 (1.0) | 9 (0.8) | 0.66 | 0.018 |
| Hypokalemia | 12 (0.8) | 13 (0.9) | 1.0 | 5 (0.5) | 13 (1.2) | 0.095 | 0.88 |
Abbreviations: CCB, calcium channel blocker; y.o., years old.
Data are n (%).